article thumbnail

Top 10 Heart and Vascular Medications Based on Recent Sales Data

XTalks

The heart and vascular medication market continues to be a critical focus area for pharma companies, with billions of dollars in sales generated annually. In this blog, we take a closer look at the top 10 heart and vascular medications based on recent sales data. Eliquis (Apixaban) Eliquis 2023 sales :$12.21

Sales 104
article thumbnail

How Market Listening Can Help Drive Your Pharma Sales Funnel

Pharma Mirror

The role of pharma sales reps is an incredibly important part of this lifecycle from initial research to point of sale and distribution, with reps connecting the groundbreaking research and technology of pharma companies with healthcare professionals and medical establishments.

Sales 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HCPs are overwhelmed by promotional content in digital

World of DTC Marketing

Further, 62% of HCPs said that the most significant area where pharma representatives can add value is, by understanding the needs of HCPs and sharing only relevant content with them to make the interactions more insightful. At the same time, marketing emails are among the top 5 channels used by pharma companies to engage HCPs.

article thumbnail

Eversana aims athletes’ mental coaching at pharma sales reps

pharmaphorum

Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. The post Eversana aims athletes’ mental coaching at pharma sales reps appeared first on.

Sales 118
article thumbnail

Four ways emerging pharma companies can launch and scale content faster

pharmaphorum

An unexpected benefit of healthcare professional (HCP) engagement going digital in 2020 is that sales teams have more opportunities to spend quality time with doctors. Read the How Emerging Pharma Can Launch and Scale Content Faster eBook from Veeva in full.

article thumbnail

More firms join litigation against Central govt on FDC ban

AuroBlog - Aurous Healthcare Clinical Trials blog

At least seven more pharma companies and a federation of pharma manufacturers have approached the Delhi High Court against the Central Government’s order in the beginning of June prohibiting manufacturing, distribution and sale of 14 fixed dose combinations (FDCs) licensed prior to the year 1988.

article thumbnail

Delhi HC grants 10 days’ time to Govt to file counter affidavit on petitions against ban of 14 FDCs

AuroBlog - Aurous Healthcare Clinical Trials blog

The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharma companies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]